Faculty Of Pharmacy 2
51. Overcoming Barriers in Hospital-Based Health Technology Assessment (HB-HTA): International Expert Panel Consensus
52. Nutritional Sources and Anticancer Potential of Phenethyl Isothiocyanate: Molecular Mechanisms and Therapeutic Insights
53. The monkeypox virus: A public health challenge threatening Africa
54. The need for health system strengthening in the wake of natural disasters: Lessons from the 2023 Türkiye–Syria earthquake
55. Global, regional, and national burden of chronic kidney disease in adults, 1990–2023, and its attributable risk factors: a systematic analysis for the Global Burden of Disease Study 2023
56. Global, regional, and national burden of chronic kidney disease in adults, 1990–2023, and its attributable risk factors: a systematic analysis for the Global Burden of Disease Study 2023
57. Global, regional, and national burden of chronic kidney disease in adults, 1990–2023, and its attributable risk factors: a systematic analysis for the Global Burden of Disease Study 2023
58. The burden of bacterial antimicrobial resistance in the WHO Eastern Mediterranean Region 1990–2021: a cross-country systematic analysis with forecasts to 2050
59. DEVELOPMENT OF ANTIFUNGAL GEL, COMPOSITION AND TECHNOLOGY BASED ON POMIFERIN METABOLITE ISOLATED FROM FRUITS OF MACLURA AURANTIACA GROWING IN KAZAKHSTAN
60. STUDY OF THE CHEMICAL COMPONENTS OF CO2 EXTRACTS FROM THE UNDERGROUND PART OF FERULA ASAFOETIDA L
61. Global burden of chronic respiratory diseases and risk factors, 1990–2019: an update from the Global Burden of Disease Study 2019
62. Global burden of chronic respiratory diseases and risk factors, 1990–2019: an update from the Global Burden of Disease Study 2019
63. Histological and Immunohistochemical Evaluation of Silver Nanoparticle-Mediated Wound Healing in Rabbits
64. Diagnostic Delay in Patients With Chronic Urticaria: Results From the Chronic Urticaria Registry (CURE)
65. How climate change and insecurity pushed 5 million people to hunger in Chad, Africa
66. Public health consequences of armed conflict in Sudan in the face of global donor fatigue
67. Global burden of bacterial antimicrobial resistance 1990–2021: a systematic analysis with forecasts to 2050
68. Global burden of bacterial antimicrobial resistance 1990–2021: a systematic analysis with forecasts to 2050
69. NUTRITIONAL AND THERAPEUTIC POTENTIAL OF BIOACTIVE COMPOUNDS FROM MELONS: A MINI REVIEW
70. Antioxidant, Anti-Tumour, and Anticoagulant Activities of Polysaccharide from Calocybe indica (APK2)
71. Synthesis, Characterization, and Application of Polyurethane-Acrylic Hybrids as Anticorrosion Coatings
72. Application of Iron Oxide Nanoparticles as MRI Contrast Enhancers: A study in Rabbits
73. Global, regional, and national prevalence of adult overweight and obesity, 1990–2021, with forecasts to 2050: a forecasting study for the Global Burden of Disease Study 2021
74. Global, regional, and national prevalence of adult overweight and obesity, 1990–2021, with forecasts to 2050: a forecasting study for the Global Burden of Disease Study 2021
75. Global, regional, and national burden of chronic respiratory diseases and impact of the COVID-19 pandemic, 1990–2023: a Global Burden of Disease study
76. Global, regional, and national burden of chronic respiratory diseases and impact of the COVID-19 pandemic, 1990–2023: a Global Burden of Disease study
77. The intersectional impact of climate change and gender inequalities in Africa
78. The Influence of Episiotomy in Childbirth on the Degree of Posterior Perineal Tear
79. Phytochemical Profile and Biological Activity of the Ethanol Extracts from the Aerial Parts of Adonis tianschanica (Adolf.) Lipsch. Growing in Kazakhstan
80. Anticancer properties of bromelain: State-of-the-art and recent trends
81. Solubility and Thermodynamic Studies of Mesalazine in 1,4-Dioxane + Water Binary Mixtures at Different Temperatures
82. Non–Skin Related Symptoms Are Common in Chronic Spontaneous Urticaria and Linked to Active and Uncontrolled Disease: Results From the Chronic Urticaria Registry
83. Spatial, temporal, and demographic patterns in prevalence of smoking tobacco use and attributable disease burden in 204 countries and territories, 1990–2019: a systematic analysis from the Global Burden of Disease Study 2019
84. MiR-186-5p inhibition restores synaptic transmission and neuronal network activity in a model of chronic stress
85. Phytochemical analysis and antioxidant activity of Berberis iliensis M. Pop and Berberis integerrima Bunge fruits pulp
86. Insights into ancestral diversity in Parkinson’s disease risk: a comparative assessment of polygenic risk scores
87. Ficus plants: State of the art from a phytochemical, pharmacological, and toxicological perspective
88. Global health at crossroads: uniting together to overcome challenges, restore trust and advance priorities for a sustainable future
89. Results of social research on assessing the needs for pharmaceutical personnel
90. Global, regional, and national burden of allergic disorders and their risk factors in 204 countries and territories, from 1990 to 2019: A systematic analysis for the Global Burden of Disease Study 2019
91. Global burden of lower respiratory infections and aetiologies, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023
92. Global burden of lower respiratory infections and aetiologies, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023
93. Global burden of lower respiratory infections and aetiologies, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023
94. Global, regional, and national burden of upper respiratory infections and otitis media, 1990-2021: a systematic analysis from the Global Burden of Disease Study 2021
95. Pyrimidine scaffold dual-target kinase inhibitors for cancer diseases: A review on design strategies, synthetic approaches, and structure–activity relationship (2018‒2023)
96. Tackling Cholera Outbreak Amidst COVID-19 Pandemic in Nigeria: Challenges and Recommendations
97. Global, Regional, and National Burden of Cardiovascular Diseases and Risk Factors in 204 Countries and Territories, 1990-2023
98. Global, Regional, and National Burden of Cardiovascular Diseases and Risk Factors in 204 Countries and Territories, 1990-2023
99. Changing life expectancy in European countries 1990–2021: a subanalysis of causes and risk factors from the Global Burden of Disease Study 2021
100. Global, regional, and national burden of disorders affecting the nervous system, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
1 2 3